细胞生物学
重新安置
免疫
细胞质
生物
核定位序列
化学
免疫系统
细胞核
核蛋白
核心
核运输
先天免疫系统
核孔
分子生物学
作者
Kai Huang,Zhaohui Tang,Qin Gong,Jianing Peng,Yicheng Rong,Tiancong Wu,Weichen Song,Siyu Mao,Yugui Xia,Wenjie Guo,Wen Liu
标识
DOI:10.1016/j.apsb.2026.06.010
摘要
DNA-damaging agents combined with agonists of the cGAS–STING pathway can effectively suppress colorectal cancer (CRC) by inducing cancer cell death and eliciting an antitumor immune response. In this study, we demonstrate that the natural compound Bruceine A (BA) inhibits CRC progression through a dual mechanism involving nuclear-to-cytoplasmic translocation of Ku70. Cytoplasmic Ku70 loses its canonical DNA repair function while simultaneously enhancing its interaction with cGAS, leading to increased cGAS oligomerization and elevated levels of double-stranded DNA (dsDNA), both of which amplify cGAS–STING signaling. Furthermore, Bruceine A-mediated Ku70 translocation exacerbates DNA damage accumulation, further enhancing tumor immunogenicity. In the murine CRC model, Bruceine A significantly inhibited tumor growth and enhanced tumor sensitivity to chemotherapy, radiotherapy, and anti-PD-1 treatment. Notably, genetic ablation of STING and CD8 + T cells in mice substantially abolished the antitumor effects of Bruceine A, confirming its reliance on cGAS–STING activation and adaptive immunity. Our findings establish Ku70 as a novel therapeutic target in CRC, where its subcellular redistribution disrupts genomic stability and bridges innate immune activation, synergistically promoting tumor cell death and antitumor immunity. Modulating Ku70 localization thus represents a promising strategy to enhance CRC treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI